TLR signaling and effector functions are intact in XLA neutrophils

Clinical Immunology

Volumn 137, Issue 1, 2010, Pages 74-80

  Marron, Thomas U ^a   Rohr, Kaileen ^a   Martinez Gallo, Monica ^a   Yu, Joyce ^a,b   Cunningham Rundles, Charlotte ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Bruton's tyrosine kinase; BTK; Neutrophils; Respiratory burst; TLR; Toll like receptors; X linked agammaglobulinemia; XLA

Indexed keywords

BRUTON TYROSINE KINASE; L SELECTIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL SURVIVAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; ENZYME ACTIVATION; HUMAN; INTRACELLULAR SIGNALING; NEUTROPHIL; PRIORITY JOURNAL; RESPIRATORY BURST; SCHOOL CHILD; WESTERN BLOTTING; X LINKED AGAMMAGLOBULINEMIA;

ADOLESCENT; ADULT; AGAMMAGLOBULINEMIA; APOPTOSIS; CHILD; GENETIC DISEASES, X-LINKED; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMIDAZOLES; L-SELECTIN; LIPOPOLYSACCHARIDES; MITOGEN-ACTIVATED PROTEIN KINASES; NEUTROPHIL ACTIVATION; NEUTROPHILS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; QUINOLINES; REACTIVE OXYGEN SPECIES; RESPIRATORY BURST; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TOLL-LIKE RECEPTORS; YOUNG ADULT;

EID: 77956616895     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.06.011     Document Type: Article

References (42)

1. Conley M.E. B cells in patients with X-linked agammaglobulinemia. J. Immunol. 1985, 134:3070-3074.
2. Vetrie D., Vorechovsky I., Sideras P., Holland J., Davies A., Flinter F., Hammarstrom L., Kinnon C., Levinsky R., Bobrow M. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases.[see comment][erratum appears in Nature 1993 Jul 22;364(6435):362]. Nature 1993, 361:226-233.
3. Conley M.E. Genetics of hypogammaglobulinemia: what do we really know?. Curr. Opin. Immunol. 2009, 21:466-471.
4. Farrar J.E., Rohrer J., Conley M.E. Neutropenia in X-linked agammaglobulinemia. Clin. Immunol. Immunopathol. 1996, 81:271-276.
5. Winkelstein J.A., Marino M.C., Lederman H.M., Jones S.M., Sullivan K., Burks A.W., Conley M.E., Cunningham-Rundles C., Ochs H.D. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine 2006, 85:193-202.
6. Howard V., Greene J.M., Pahwa S., Winkelstein J.A., Boyle J.M., Kocak M., Conley M.E. The health status and quality of life of adults with X-linked agammaglobulinemia. Clin. Immunol. 2006, 118:201-208.
7. Winkelstein J.A., Conley M.E., James C., Howard V., Boyle J. Adults with X-linked agammaglobulinemia: impact of disease on daily lives, quality of life, educational and socioeconomic status, knowledge of inheritance, and reproductive attitudes. Medicine 2008, 87:253-258.
8. Qiu Y., Kung H.J. Signaling network of the Btk family kinases. Oncogene 2000, 19:5651-5661.
9. Doyle S.L., Jefferies C.A., Feighery C., O'Neill L.A. Signaling by Toll-like receptors 8 and 9 requires Bruton's tyrosine kinase. J. Biol. Chem. 2007, 282:36953-36960.
10. Doyle S.L., Jefferies C.A., O'Neill L.A. Bruton's tyrosine kinase is involved in p65-mediated transactivation and phosphorylation of p65 on serine 536 during NFkappaB activation by lipopolysaccharide. J. Biol. Chem. 2005, 280:23496-23501.
11. Hasan M., Lopez-Herrera G., Blomberg K.E., Lindvall J.M., Berglof A., Smith C.I., Vargas L. Defective Toll-like receptor 9-mediated cytokine production in B cells from Bruton's tyrosine kinase-deficient mice. Immunology 2008, 123:239-249.
12. Jefferies C.A., Doyle S., Brunner C., Dunne A., Brint E., Wietek C., Walch E., Wirth T., O'Neill L.A. Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4. J. Biol. Chem. 2003, 278:26258-26264.
13. Kumar H., Kawai T., Akira S. Pathogen recognition in the innate immune response. Biochem. J. 2009, 420:1-16.
14. Lee K.G., Xu S., Wong E.T., Tergaonkar V., Lam K.P. Bruton's tyrosine kinase separately regulates NFkappaB p65RelA activation and cytokine interleukin (IL)-10/IL-12 production in TLR9-stimulated B Cells. J. Biol. Chem. 2008, 283:11189-11198.
15. Liljeroos M., Vuolteenaho R., Morath S., Hartung T., Hallman M., Ojaniemi M. Bruton's tyrosine kinase together with PI 3-kinase are part of Toll-like receptor 2 multiprotein complex and mediate LTA induced Toll-like receptor 2 responses in macrophages. Cell. Signal. 2007, 19:625-633.
16. Mangla A., Khare A., Vineeth V., Panday N.N., Mukhopadhyay A., Ravindran B., Bal V., George A., Rath S. Pleiotropic consequences of Bruton tyrosine kinase deficiency in myeloid lineages lead to poor inflammatory responses. Blood 2004, 104:1191-1197.
17. Schmidt N.W., Thieu V.T., Mann B.A., Ahyi A.N., Kaplan M.H. Bruton's tyrosine kinase is required for TLR-induced IL-10 production. J. Immunol. 2006, 177:7203-7210.
18. Sochorova K., Horvath R., Rozkova D., Litzman J., Bartunkova J., Sediva A., Spisek R. Impaired Toll-like receptor 8-mediated IL-6 and TNF-alpha production in antigen-presenting cells from patients with X-linked agammaglobulinemia. Blood 2007, 109:2553-2556.
19. Taneichi H., Kanegane H., Sira M.M., Futatani T., Agematsu K., Sako M., Kaneko H., Kondo N., Kaisho T., Miyawaki T. Toll-like receptor signaling is impaired in dendritic cells from patients with X-linked agammaglobulinemia. Clin. Immunol. 2008, 126:148-154.
20. Mukhopadhyay S., Mohanty M., Mangla A., George A., Bal V., Rath S., Ravindran B. Macrophage effector functions controlled by Bruton's tyrosine kinase are more crucial than the cytokine balance of T cell responses for microfilarial clearance. J. Immunol. 2002, 168:2914-2921.
21. Reid R.R., Prodeus A.P., Khan W., Hsu T., Rosen F.S., Carroll M.C. Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide. J. Immunol. 1997, 159:970-975.
22. Horwood N.J., Page T.H., McDaid J.P., Palmer C.D., Campbell J., Mahon T., Brennan F.M., Webster D., Foxwell B.M. Bruton's tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production. J. Immunol. 2006, 176:3635-3641.
23. Kadowaki N., Ho S., Antonenko S., Malefyt R.W., Kastelein R.A., Bazan F., Liu Y.J. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 2001, 194:863-869.
24. Hayashi F., Means T.K., Luster A.D. Toll-like receptors stimulate human neutrophil function. Blood 2003, 102:2660-2669.
25. Singh A., Zarember K.A., Kuhns D.B., Gallin J.I. Impaired priming and activation of the neutrophil NADPH oxidase in patients with IRAK4 or NEMO deficiency. J. Immunol. 2009, 182:6410-6417.
26. Bouma G., Doffinger R., Patel S.Y., Peskett E., Sinclair J.C., Barcenas-Morales G., Cerron-Gutierrez L., Kumararatne D.S., Davies E.G., Thrasher A.J., Burns S.O. Impaired neutrophil migration and phagocytosis in IRAK-4 deficiency. Br. J. Haematol. 2009, 147:153-156.
27. Kozlowski C., Evans D.I. Neutropenia associated with X-linked agammaglobulinaemia. J. Clin. Pathol. 1991, 44:388-390.
28. Lee A., Whyte M.K., Haslett C. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J. Leukoc. Biol. 1993, 54:283-288.
29. Elbim C., Lizard G. Flow cytometric investigation of neutrophil oxidative burst and apoptosis in physiological and pathological situations. Cytom. A 2009, 75:475-481.
30. Klein J.B., Rane M.J., Scherzer J.A., Coxon P.Y., Kettritz R., Mathiesen J.M., Buridi A., McLeish K.R. Granulocyte-macrophage colony-stimulating factor delays neutrophil constitutive apoptosis through phosphoinositide 3-kinase and extracellular signal-regulated kinase pathways. J. Immunol. 2000, 164:4286-4291.
31. Zorn C.N., Keck S., Hendriks R.W., Leitges M., Freudenberg M.A., Huber M. Bruton's tyrosine kinase is dispensable for the Toll-like receptor-mediated activation of mast cells. Cell. Signal. 2009, 21:79-86.
32. Horwood N.J., Mahon T., McDaid J.P., Campbell J., Mano H., Brennan F.M., Webster D., Foxwell B.M. Bruton's tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor alpha production. J. Exp. Med. 2003, 197:1603-1611.
33. Jyonouchi H., Geng L., Toruner G.A., Vinekar K., Feng D., Fitzgerald-Bocarsly P. Monozygous twins with a microdeletion syndrome involving BTK, DDP1, and two other genes; evidence of intact dendritic cell development and TLR responses. Eur. J. Pediatr. 2008, 167:317-321.
34. Perez de Diego R., Lopez-Granados E., Pozo M., Rodriguez C., Sabina P., Ferreira A., Fontan G., Garcia-Rodriguez M.C., Alemany S. Bruton's tyrosine kinase is not essential for LPS-induced activation of human monocytes. J. Allergy Clin. Immunol. 2006, 117:1462-1469.
35. Kuhns D.B., Long Priel D.A., Gallin J.I. Loss of L-selectin (CD62L) on human neutrophils following exudation in vivo. Cell. Immunol. 1995, 164:306-310.
36. von Bernuth H., Picard C., Jin Z., Pankla R., Xiao H., Ku C.L., Chrabieh M., Mustapha I.B., Ghandil P., Camcioglu Y., Vasconcelos J., Sirvent N., Guedes M., Vitor A.B., Herrero-Mata M.J., Arostegui J.I., Rodrigo C., Alsina L., Ruiz-Ortiz E., Juan M., Fortuny C., Yague J., Anton J., Pascal M., Chang H.H., Janniere L., Rose Y., Garty B.Z., Chapel H., Issekutz A., Marodi L., Rodriguez-Gallego C., Banchereau J., Abel L., Li X., Chaussabel D., Puel A., Casanova J.L. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 2008, 321:691-696.
37. Aomatsu K., Kato T., Fujita H., Hato F., Oshitani N., Kamata N., Tamura T., Arakawa T., Kitagawa S. Toll-like receptor agonists stimulate human neutrophil migration via activation of mitogen-activated protein kinases. Immunology 2008, 123:171-180.
38. Sabroe I., Dower S.K., Whyte M.K. The role of Toll-like receptors in the regulation of neutrophil migration, activation, and apoptosis. Clin. Infect. Dis. 2005, 41(Suppl 7):S421-S426.
39. Kim T.W., Staschke K., Bulek K., Yao J., Peters K., Oh K.H., Vandenburg Y., Xiao H., Qian W., Hamilton T., Min B., Sen G., Gilmour R., Li X. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity. J. Exp. Med. 2007, 204:1025-1036.
40. Orange J.S., Jain A., Ballas Z.K., Schneider L.C., Geha R.S., Bonilla F.A. The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation. J. Allergy Clin. Immunol. 2004, 113:725-733.
41. Ellmeier W., Jung S., Sunshine M.J., Hatam F., Xu Y., Baltimore D., Mano H., Littman D.R. Severe B cell deficiency in mice lacking the tec kinase family members Tec and Btk. J. Exp. Med. 2000, 192:1611-1624.
42. Lachance G., Levasseur S., Naccache P.H. Chemotactic factor-induced recruitment and activation of Tec family kinases in human neutrophils. Implication of phosphatidynositol 3-kinases. J. Biol. Chem. 2002, 277:21537-21541.